Physician profile
Concepto Flores
NPI 1427117209
$16,520.32
in general payments reported to CMS, 2019-2025
51 companies · $2,293 in 2025
The $2,293 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,032 · 2020: $2,078 · 2021: $2,410 · 2022: $2,935 · 2023: $2,570 · 2024: $2,202 · 2025: $2,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,064.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,248.24 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,662.82 | 2019-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,435.41 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $1,419.29 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $1,214.38 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $999.67 | 2020-2025 | |
| Pfizer INC. | $775.41 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $657.60 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $579.99 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $522.64 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Otsuka America Pharmaceutical, INC. | $429.45 | 2023-2025 | Rexulti, Nuedexta |
| Amgen INC. | $389.41 | 2019-2025 | Repatha, Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $365.04 | 2019-2022 | |
| Allergan, INC. | $356.91 | 2019-2021 | |
| Exact Sciences Corporation | $301.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $284.80 | 2021-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $254.94 | 2019-2024 | Verquvo, Belsomra |
| Dexcom, INC. | $250.56 | 2021-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $215.05 | 2019-2024 | Trintellix |
| Biohaven Pharmaceutical Holding Company LTD. | $188.15 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $186.03 | 2020-2023 | Eliquis |
| Biohaven Pharmaceuticals, INC. | $177.32 | 2021 | |
| Ironwood Pharmaceuticals, INC | $159.14 | 2022-2024 | Linzess |
| Ultragenyx Pharmaceutical INC. | $137.74 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $126.87 | 2020-2023 | |
| Teva Pharmaceuticals USA, INC. | $122.82 | 2019-2021 | |
| Astellas Pharma US INC | $114.89 | 2019-2025 | Veozah |
| Kyowa Kirin, INC. | $107.38 | 2024-2025 | Crysvita |
| Lundbeck LLC | $97.94 | 2023-2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $93.13 | 2024-2025 | Voquezna |
| Avanir Pharmaceuticals, INC. | $92.47 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $91.99 | 2025 | Caplyta |
| Esperion Therapeutics, INC. | $58.58 | 2020-2021 | |
| Medtronic, INC. | $55.82 | 2022-2023 | Venaseal |
| Gilead Sciences, INC. | $52.42 | 2019 | |
| Idorsia Pharmaceuticals US INC | $39.36 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $34.26 | 2025 | Symbravo |
| Nevro Corp. | $22.61 | 2022 | |
| Seqirus USA INC | $19.00 | 2019 | |
| Grifols USA, LLC | $18.98 | 2025 | Prolastin-C Liquid |
| Biogen, INC. | $18.76 | 2019 | |
| Verona Pharma, INC. | $18.02 | 2025 | Ohtuvayre |
| Insulet Corporation | $15.60 | 2024 | Omnipod |
| Philips North America LLC | $14.40 | 2021 | |
| Orexo US, INC. | $14.20 | 2021 | |
| Horizon Therapeutics Plc | $14.19 | 2022 | |
| Shield Therapeutics INC | $13.90 | 2023 | Accrufer |
| Pulmonx Corporation | $13.48 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Kowa Pharmaceuticals America, INC. | $13.40 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.66 | 2020 | |
| Vifor Pharma, INC. | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Concepto Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.